IMNM

Immunome (IMNM)

About Immunome (IMNM)

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Details

Daily high

$10.57

Daily low

$10.11

Price at open

$10.42

52 Week High

$30.96

52 Week Low

$8.97

Market cap

657.9M

Dividend yield

0.00%

Volume

155,353

Avg. volume

878,091

P/E ratio

-1.30

Immunome News